SUNNYVALE, Calif. , Sept. 15 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Accuray's Board of Directors has appointed Louis J. Lavigne, Jr. and Dennis L. Winger as members of the company's Board of Directors.
Milestone System to Handle Full Patient Load for New, Integrated Cancer Center in Scottsdale, Arizona SUNNYVALE, Calif. , May 22, 2014 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the installation of its 500 th TomoTherapy® System at the grand opening of Palo Verde Cancer
Latest Collaboration with Leading Research Institution Continues Partnership in New Technology Development SUNNYVALE, Calif. , May 22, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the signing of a multi-year master research and
Siemens to Expand Distribution of CyberKnife Systems As Part of its Global Product Portfolio Accuray and Siemens to Create Long-Term Research and Development Relationship to Identify Potential New Technologies and Products SUNNYVALE, Calif., June 9, 2010 /PRNewswire via COMTEX/ --Accuray (Nasdaq:
RayStation® will be Extended to Include Treatment Planning for the TomoTherapy® and CyberKnife® Systems SUNNYVALE, Calif. , and STOCKHOLM , Oct. 5, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) and RaySearch Laboratories AB (publ) (NASDAQ OMX Stockholm: RAY B) announced today that they
SUNNYVALE, Calif. and STOCKHOLM , July 13, 2015 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) and RaySearch Laboratories AB (publ) (NASDAQ OMX Stockholm: RAY B) announced today they have signed a long-term collaboration agreement which will allow Accuray to co-market and offer the RayCare ®
MADISON, Wis. , Oct. 2, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has a 510(k) pending for an online adaptive therapy option*, Cenos™, for its Radixact ® System. The solution was unveiled, in partnership with Limbus AI, at the 2023 ASTRO ( American
Partnership will Enable Accuray to Use Limbus' Technology to Streamline the Treatment Planning Process and Increase Operational Efficiency SUNNYVALE, Calif. and SASKATCHEWAN, Canada , June 2, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and Limbus AI Inc.
Partnership Creates Strategic Alliance for Advancement of Research in Radiation Oncology in the Netherlands SUNNYVALE, Calif. , June 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the signing of a multi-year master research and
SUNNYVALE , Calif. and WESTERVILLE, Ohio , Nov. 18, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and DHL Supply Chain announced today they have entered into a global service parts logistics partnership that will further strengthen the Accuray aftermarket supply chain and expand the
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
